143 related articles for article (PubMed ID: 1913613)
1. Numerical chromosome abnormalities associated with early clinical stages of gynecologic tumors.
Tharapel SA; Qumsiyeh MB; Photopulos G
Cancer Genet Cytogenet; 1991 Aug; 55(1):89-96. PubMed ID: 1913613
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of S-phase fraction as measured by DNA flow cytometry in gynecologic malignancies.
Strang P; Stendahl U; Tribukait B
Ann N Y Acad Sci; 1993 Mar; 677():354-63. PubMed ID: 8494220
[No Abstract] [Full Text] [Related]
3. Structural chromosomal abnormalities in gynecologic malignancies.
Huber H; Knogler W; Karlic H; Akrad M; Söregi G; Schweizer D
Cancer Genet Cytogenet; 1990 Dec; 50(2):189-97. PubMed ID: 1702358
[TBL] [Abstract][Full Text] [Related]
4. Ploidy in gynaecological cancers.
Fox H
Histopathology; 2005 Feb; 46(2):121-9. PubMed ID: 15693883
[No Abstract] [Full Text] [Related]
5. Karyotype analysis of four solid gynecologic tumors.
Kusyk CJ; Turpening EL; Edwards CL; Wharton JT; Copeland LJ
Gynecol Oncol; 1982 Dec; 14(3):324-38. PubMed ID: 6961093
[No Abstract] [Full Text] [Related]
6. Cytogenetic studies of endometrial malignancies.
Milatovich A; Heerema NA; Palmer CG
Cancer Genet Cytogenet; 1990 May; 46(1):41-53. PubMed ID: 2331682
[TBL] [Abstract][Full Text] [Related]
7. Involvement of chromosome 6 in endometrial cancer.
Tibiletti MG; Bernasconi B; Taborelli M; Furlan D; Fabbri A; Franchi M; Taramelli R; Trubia M; Capella C
Br J Cancer; 1997; 75(12):1831-5. PubMed ID: 9192990
[TBL] [Abstract][Full Text] [Related]
8. Chromosome abnormalities in primary endometrioid ovarian carcinoma.
Yonescu R; Currie JL; Hedrick L; Campbell J; Griffin CA
Cancer Genet Cytogenet; 1996 Apr; 87(2):167-71. PubMed ID: 8625265
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic and FISH analysis of endometrial carcinoma.
Shah NK; Currie JL; Rosenshein N; Campbell J; Long P; Abbas F; Griffin CA
Cancer Genet Cytogenet; 1994 Apr; 73(2):142-6. PubMed ID: 8174089
[TBL] [Abstract][Full Text] [Related]
10. Molecular staging of gynecological cancer: What is the future?
Binder PS; Prat J; Mutch DG
Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):776-89. PubMed ID: 25934522
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetics of gynecologic neoplasms.
Wakonig-Vaartaja T; Auersperg N
Clin Obstet Gynecol; 1970 Dec; 13(4):813-30. PubMed ID: 4930554
[No Abstract] [Full Text] [Related]
12. Simple numerical chromosome aberrations in well-differentiated malignant epithelial tumors.
Pejovic T; Heim S; Orndal C; Jin YS; Mandahl N; Willén H; Mitelman F
Cancer Genet Cytogenet; 1990 Oct; 49(1):95-101. PubMed ID: 2397477
[TBL] [Abstract][Full Text] [Related]
13. Wilms tumor gene immunoreactivity in primary serous carcinomas of the fallopian tube, ovary, endometrium, and peritoneum.
Hashi A; Yuminamochi T; Murata S; Iwamoto H; Honda T; Hoshi K
Int J Gynecol Pathol; 2003 Oct; 22(4):374-7. PubMed ID: 14501819
[TBL] [Abstract][Full Text] [Related]
14. Utility of peritoneal washing cytology in staging and prognosis of ovarian and fallopian tube neoplasms: a 10-year retrospective analysis.
Davidson W; Madan R; O'Neil M; Tawfik OW; Fan F
Ann Diagn Pathol; 2016 Jun; 22():54-7. PubMed ID: 27180061
[TBL] [Abstract][Full Text] [Related]
15. Recurrent cytogenetic aberrations in human ovarian carcinomas.
Kiechle-Schwarz M; Bauknecht T; Schmidt J; Walz L; Pfleiderer A
Cancer Detect Prev; 1995; 19(3):234-43. PubMed ID: 7750111
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients.
Zuna RE; Behrens A
J Natl Cancer Inst; 1996 Jul; 88(14):980-7. PubMed ID: 8667429
[TBL] [Abstract][Full Text] [Related]
17. Four synchronous female genital malignancies: the ovary, cervix, endometrium and fallopian tube.
Saglam A; Bozdag G; Kuzey GM; Kuçukali T; Ayhan A
Arch Gynecol Obstet; 2008 Jun; 277(6):557-62. PubMed ID: 18066567
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous squamous cell carcinomas of the uterine cervix and upper genital tract: loss of heterozygosity analysis demonstrates clonal neoplasms of cervical origin.
Kushima M; Fujii H; Murakami K; Ota H; Matsumoto T; Motoyama T; Kiyokawa T; Ishikura H
Int J Gynecol Pathol; 2001 Oct; 20(4):353-8. PubMed ID: 11603219
[TBL] [Abstract][Full Text] [Related]
19. Trisomy 21 as the only recurrent chromosomal anomaly in a clinically aggressive ovarian carcinoma.
Faruqi SA; Noumoff MJ; Deger RB; Jalal SM; Antoniades K
Cancer Genet Cytogenet; 2002 Oct; 138(2):165-8. PubMed ID: 12505265
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D
Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
